| dbo:abstract
|
- Haemochromatosis type 3 is a type of iron overload disorder associated with deficiencies in transferrin receptor 2. It exhibits an autosomal recessive inheritance pattern. The first confirmed case was diagnosed in 1865 by French doctor Trousseau. Later in 1889, the German doctor von Recklinghausen indicated that the liver contains iron, and due to bleeding being considered to be the cause, he called the pigment "Haemochromatosis." In 1935, English doctor Sheldon's groundbreaking book titled, Haemochromatosis, reviewed 311 patient case reports and presented the idea that haemochromatosis was a congenital metabolic disorder. Hereditary haemochromatosis is a congenital disorder which affects the regulation of iron metabolism thus causing increased gut absorption of iron and a gradual build-up of pathologic iron deposits in the liver and other internal organs, joint capsules and the skin. The iron overload could potentially cause serious disease from the age of 40–50 years. In the final stages of the disease, the major symptoms include liver cirrhosis, diabetes and bronze-colored skin. There are four types of hereditary hemochromatosis which are classified depending on the age of onset and other factors such as genetic cause and mode of inheritance. (en)
- L' hémochromatose par mutation TFR2 comme l'hémochromatose par mutation HFE est un trouble de l'absorption du fer avec accumulation de ce métal dans le foie, le cœur et les glandes endocrines. Les signes de la maladie sont des douleurs, une asthénie, des arthralgies ou une diminution de la libido, mais le plus souvent il existe seulement des signes biologiques. L'âge de début est souvent plus tôt que l'hémochromatose par mutation HFE. L'évolution est beaucoup plus lente et parfois aucune complication n'apparaît même en l'absence de traitement. Les complications sont la cirrhose, des manifestations articulaires et l'hypogonadisme hypogonadotrope. (fr)
|
| dbo:icd10
| |
| dbo:meshId
| |
| dbo:omim
| |
| dbo:orpha
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 17446 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:field
| |
| dbp:icd
| |
| dbp:meshid
| |
| dbp:name
|
- Haemochromatosis type 3 (en)
|
| dbp:omim
| |
| dbp:orphanet
| |
| dbp:synonyms
|
- TFR2-related hemochromatosis (en)
|
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- Haemochromatosis type 3 is a type of iron overload disorder associated with deficiencies in transferrin receptor 2. It exhibits an autosomal recessive inheritance pattern. The first confirmed case was diagnosed in 1865 by French doctor Trousseau. Later in 1889, the German doctor von Recklinghausen indicated that the liver contains iron, and due to bleeding being considered to be the cause, he called the pigment "Haemochromatosis." In 1935, English doctor Sheldon's groundbreaking book titled, Haemochromatosis, reviewed 311 patient case reports and presented the idea that haemochromatosis was a congenital metabolic disorder. Hereditary haemochromatosis is a congenital disorder which affects the regulation of iron metabolism thus causing increased gut absorption of iron and a gradual build-up (en)
- L' hémochromatose par mutation TFR2 comme l'hémochromatose par mutation HFE est un trouble de l'absorption du fer avec accumulation de ce métal dans le foie, le cœur et les glandes endocrines. Les signes de la maladie sont des douleurs, une asthénie, des arthralgies ou une diminution de la libido, mais le plus souvent il existe seulement des signes biologiques. (fr)
|
| rdfs:label
|
- Haemochromatosis type 3 (en)
- Hémochromatose par mutation TFR2 (fr)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Haemochromatosis type 3 (en)
|
| is dbo:differentialDiagnosis
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
